Artelo Biosciences Inc.
13F holders, Q4 2024 (December 31)6holders +1
1new positions
0sold out
$1.06avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Artelo Biosciences Inc. in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($18K), UBS Group AG ($14K) and Tower Research Capital LLC (TRC) ($4K).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G508
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $14K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 13,297 shares bought and 1,365 shares sold, net +11,932 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Geode Capital Management, LLC | 0.00% | No change | 17,350 | $18K |
| UBS Group AG | 0.00% | New | 13,297 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -26.3% | 3,818 | $4K |
| Bank of America Corp. | 0.00% | No change | 26 | $28 |
| Morgan Stanley | 0.00% | No change | 20 | $21 |
| Rothschild Investment LLC | 0.00% | No change | 8 | $8 |
"% of holder's portfolio" is ARTELO BIOSCIENCES INC's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.